[Coronary Artery Bypass Grafting and Biventricular Pacing for Severe Heart Failure due to Dilated Cardiomyopathy]

Hiromitsu Teratani1, Toshihiro Fujimatsu, Hiroyuki Suzuki

  • 1Division of Cardiovascular Surgery, Heart Center, Hokuto Hospital, Obihiro, Japan.

Insights

Biventricular pacing with surgical epicardial leads improved left ventricular systolic function in a patient with severe heart failure. This approach offers a potential option for cardiac resynchronization therapy during open heart surgery.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Electrophysiology

Context:

  • A 57-year-old male patient presented with dilated cardiomyopathy and coronary stenosis.
  • Initial medical therapy provided temporary relief, but symptoms recurred, leading to readmission for severe heart failure.
  • The patient exhibited a complete left bundle branch block and prolonged QRS interval, indicative of conduction system disease.

Purpose:

  • To evaluate the efficacy of biventricular pacing with surgical epicardial leads in a patient with severe left ventricular systolic dysfunction and heart failure.
  • To assess the impact of combined coronary artery bypass grafting and cardiac resynchronization therapy on cardiac function.

Summary:

  • Coronary artery bypass grafting and biventricular pacing with surgical epicardial leads were performed due to aggravated left ventricular systolic dysfunction and coronary artery stenosis.
  • The combined surgical intervention resulted in significant improvement in left ventricular systolic function.
  • Post-operative recovery demonstrated the effectiveness of the chosen therapeutic strategy.

Impact:

  • Biventricular pacing using surgical epicardial leads presents a viable therapeutic option for patients undergoing open heart surgery for severe left ventricular systolic dysfunction.
  • This case highlights the successful application of cardiac resynchronization therapy in managing complex cardiac conditions.
  • The findings support further investigation into this combined approach for heart failure management.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
656
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
583
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
469